Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study. (Q55461530)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study. |
scientific article |
Statements
1 reference
Sorafenib plus daily low-dose temozolomide for relapsed glioblastoma: a phase II study. (English)
1 reference
1 reference
Fable Zustovich
1 reference
Lorenza Landi
1 reference
Giuseppe Lombardi
1 reference
Luca Galli
1 reference
Andrea Fontana
1 reference
Domenico Amoroso
1 reference
Costanza Galli
1 reference
Michele Andreuccetti
1 reference
Alfredo Falcone
1 reference
Vittorina Zagonel
1 reference
1 August 2013
1 reference
33
1 reference
3487-3494
1 reference
8
1 reference
Identifiers
1 reference